Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Luckenbaugh

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
The American Journal of Psychiatry|August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD StudyRodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
Journal of Affective Disorders|October 19, 2004
Evidence for continuing neuropsychological impairments in depressionPetra Weiland-Fiedler, Kristine Erickson, Tracy Waldeck, et al.
Psychopharmacology Bulletin|July 25, 2009
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?Alan G Mallinger, Ellen Frank, Michael E Thase, et al.
Journal of Affective Disorders|March 23, 2013
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot studyJose A Franco-Chaves, Camilo F Mateus, David A Luckenbaugh, et al.
Journal of Psychiatric Research|November 5, 2016
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depressionMinkyung Park, Laura E Newman, Philip W Gold, et al.
Biological Psychiatry|October 10, 2006
Regional cerebral glucose metabolic abnormalities in bipolar II depressionLinda Mah, Carlos A Zarate, Jaskaran Singh, et al.
Peerj|July 16, 2014
SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administrationRezvan Ameli, David A Luckenbaugh, Neda F Gould, et al.
Biological Psychiatry|June 26, 2007
5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depressionGregor Hasler, Robert Bonwetsch, Giampiero Giovacchini, et al.
Bipolar Disorders|September 18, 2012
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depressionDavid A Luckenbaugh, Lobna Ibrahim, Nancy Brutsche, et al.
Pediatrics|June 3, 2006
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorderMonique Ernst, David A Luckenbaugh, Eric T Moolchan, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
The American Journal of Psychiatry|August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD StudyRodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
Journal of Affective Disorders|October 19, 2004
Evidence for continuing neuropsychological impairments in depressionPetra Weiland-Fiedler, Kristine Erickson, Tracy Waldeck, et al.
Psychopharmacology Bulletin|July 25, 2009
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?Alan G Mallinger, Ellen Frank, Michael E Thase, et al.
Journal of Affective Disorders|March 23, 2013
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot studyJose A Franco-Chaves, Camilo F Mateus, David A Luckenbaugh, et al.
Journal of Psychiatric Research|November 5, 2016
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depressionMinkyung Park, Laura E Newman, Philip W Gold, et al.
Biological Psychiatry|October 10, 2006
Regional cerebral glucose metabolic abnormalities in bipolar II depressionLinda Mah, Carlos A Zarate, Jaskaran Singh, et al.
Peerj|July 16, 2014
SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administrationRezvan Ameli, David A Luckenbaugh, Neda F Gould, et al.
Biological Psychiatry|June 26, 2007
5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depressionGregor Hasler, Robert Bonwetsch, Giampiero Giovacchini, et al.
Bipolar Disorders|September 18, 2012
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depressionDavid A Luckenbaugh, Lobna Ibrahim, Nancy Brutsche, et al.
Pediatrics|June 3, 2006
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorderMonique Ernst, David A Luckenbaugh, Eric T Moolchan, et al.
Pageof 14